MASTERPLAN: Study of the role of nurse practitioners in a multifactorial intervention to reduce cardiovascular risk in chronic kidney disease patients

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 261-267

  van Zuilen, Arjan D ^a   Wetzels, Jack F M ^b   Bots, Michiel L ^a   Blankestijn, Peter J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adherence to treatment goals; Cardiovascular disease; Motivational interviewing; Nursing care; Prevention

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MOTIVATION; MULTICENTER STUDY; NURSE PRACTITIONER; NURSING CARE; PARATHYROID HORMONE BLOOD LEVEL; PATIENT COUNSELING; PHOSPHATE BLOOD LEVEL; PHYSICAL ACTIVITY; PHYSICIAN; PRACTICE GUIDELINE; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SELF CARE; SMOKING CESSATION; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; CHRONIC DISEASE; KIDNEY DISEASE; MIDDLE AGED; NURSING;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; GUIDELINE ADHERENCE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; NURSE PRACTITIONERS; RISK REDUCTION BEHAVIOR;

EID: 52049127085     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
2. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol. 2006;17:2034-2047.
3. Weiner DE, Tighiouart H, Amin MG, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15:1307-1315.
4. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529-538.
5. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis. 2003;41(Suppl 3):S1-91.
6. Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(Suppl 2):ii1-ii47.
7. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease in adults. Am J Kidney Dis. 2006;47:S16-S85.
8. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines for chronic kidney disease. evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(Suppl 1):S1-S266.
9. Eknoyan G, Levin A, Levin NW. Bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42:1-201.
10. National Kidney Foundation. K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis. 2004;(Suppl 1)43:11-13.
11. National Kidney Foundation. NKF-K/DOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49:S12-S154.
12. Ter Wee PM, Jorna AT. [Treatment of patients with chronic renal insufficiency; a guideline for internists] [article in Dutch]. Ned Tijdschr Geneeskd. 2004;148:719-724.
13. Tonelli M, Bohm C, Pandeya S, Gill J, Levin A, Kiberd B. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis. 2001;37:484-489.
14. De Nicola L, Minutolo R, Chiodini P, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int. 2006;69:538-545.
15. Rabelink TJ. Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor? Nephrol Dial Transplant. 2004;19:23-26.
16. Hebert LA, Wilmer WA, Falkenhain ME, Ladson-Wofford SE, Nahman NS Jr, Rovin BH. Renoprotection: one or many therapies? Kidney Int. 2001;59:1211-1226.
17. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
18. Hemmelgarn BR, Manns BJ, Zhang J, et al. Association between multidisciplinary care and survival for elderly patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:993-999.
19. Mundinger MO, Kane RL, Lenz ER, et al. Primary care outcomes in patients treated by nurse practitioners or physicians: a randomized trial. JAMA. 2000;283:59-68.
20. Oliveria SA, Lapuerta P, McCarthy BD, L'Italien GJ, Berlowitz DR, Asch SM. Physician-related barriers to the effective management of uncontrolled hypertension. Arch Intern Med. 2002;162:413-420.
21. Van Zuilen AD, Wetzels JF, Blankestijn PJ, et al. Rationale and design of the MASTERPLAN study: multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners. J Nephrol. 2005;18:30-34.
22. Van Zuilen AD, Van der Tweel I, Blankestijn PJ, et al. Multifactorial approach and superior treatment efficacy in renal patients with the aid of nurse practitioners: design of The MASTERPLAN Study [ISRCTN73187232]. Trials. 2006;7:8.
23. Whitehead J. The Design and Analysis of Sequential Clinical Trials. 2nd ed. Chichester: John Wiley & Sons; 1997.
24. MPS Research Unit. Pest 4: Operating Manual. Reading: University of Reading; 2000.
25. Garg AX, Clark WF, Haynes RB, House AA. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002;61:1486-1494.
26. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
27. Kasiske BL. Clinical practice guidelines for managing dyslipidemias in kidney transplant patients. Am J Transplant. 2005;5:1576.
28. Rutten G, De Grauw W, Nijpels G, et al. NHG-standaard diabetes mellitus type 2, tweede herziening [article in Dutch]. Huisarts Wet. 2006;49:137-152.
29. Gezondheidsraad. Voedingsnormen: energie, eiwitten, vetten en verteerbare koolhydraten. Publication no. 2001/19 ed. Den Haag: Gezondheidsraad; 2001.
30. Kemper HGC, Ooijendijk WTM, Stiggelbout M. Consensus over de Nederlandse Norm voor Gezond Bewegen [article in Dutch]. Tijdschr Soc Gezondheidsz. 2000;78:180-183.
31. Gaede P, Beck M, Vedel P, Pedersen O. Limited impact of lifestyle education in patients with Type 2 diabetes mellitus and microalbuminuria: results from a randomized intervention study. Diabet Med. 2001;18:104-108.
32. Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469-2475.
33. Miller WR, Rollnick S. Motivational Interviewing: Preparing People for Change. 2nd ed. New York: Guilford Press; 2002.